TITLE

The Efficacy and Safety of Bile Acid Binding Agents, Opioid Antagonists, or Rifampin in the Treatment of Cholestasis-Associated Pruritus

AUTHOR(S)
Tandon, Puneeta; Rowe, Brian H.; Vandermeer, Ben; Bain, Vincent G.
PUB. DATE
July 2007
SOURCE
American Journal of Gastroenterology;Jul2007, Vol. 102 Issue 7, p1528
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVES: The objective of this review was to evaluate the efficacy and safety of rifampin, opioid antagonists, or bile acid binding agents in the treatment of cholestasis-related pruritus (CAP) from available randomized controlled trial evidence. METHODS: In addition to a comprehensive gray literature search, the Cochrane Library, MEDLINE, EMBASE, PubMed, and Web of Science were searched. Only full-text RCTs in participants (>75% adult) with CAP on at least one of the three medications were included. The primary outcome was change in pruritus score, recorded as a continuous or dichotomous outcome. Two independent reviewers performed trial selection and quality assessment. RESULTS: From 487 citations, 12 RCTs were included. Rifampin (standardized mean difference [SMD]–1.62, 95% CI –3.05 to –0.18) and opioid antagonists (SMD –0.68, 95% CI –1.19 to –0.17) significantly reduced CAP. The two cholestyramine studies were too heterogeneous to pool. Although cholestyramine ( P= 0.35) and rifampin ( P= 0.96) were not associated with greater side effects compared with placebo, opioid antagonists were (number needed to harm = 2.6, 95% CI 1.4–25). CONCLUSIONS: The available RCTs are small, few in number, and use varying scales for measuring pruritus. Although both opioid antagonists and rifampin demonstrated a reduction in pruritus, there were insufficient data to judge the efficacy of cholestyramine. Opioid antagonists were associated with transient side effects in a significant proportion of patients. A longer well-designed randomized controlled trial is needed to confirm the efficacy of bile acid binding agents and accurately assess adverse events.
ACCESSION #
25489330

 

Related Articles

  • Longitudinal Profiles of 15 Serum Bile Acids in Patients With Intrahepatic Cholestasis of Pregnancy. Tribe, Rachel M.; Dann, Anthony T.; Kenyon, Anna P.; Seed, Paul; Shennan, Andrew H.; Mallet, Anthony // American Journal of Gastroenterology;Mar2010, Vol. 105 Issue 3, p585 

    OBJECTIVES:Increased maternal serum bile acids are implicated in intrahepatic cholestasis of pregnancy. Individual bile acid profiles and their relationship with disease progression, however, remain unknown. The purpose of this prospective study was to determine the temporal changes in bile...

  • Treatment Effect of Rifampicin on Cholestasis. Chen, Jiezhong; Raymond, Kenneth // Internet Journal of Pharmacology;2006, Vol. 4 Issue 2, p4 

    Rifampicin, a semisynthetic antibiotic, has been discovered serendipitously to have beneficial effect on cholestasis. The mechanism, as recently demonstrated, is its induction of pregnane X receptor to regulate the genes involved in bile acids biosynthesis, detoxification and transportation....

  • Pruritus of Cholestasis Treated with Plasma Perfusion. Carey, William D.; Smith, James; Asanuma, Yoshihiro; Malchesky, Paul; Ferguson, D. Roy; Greenstreet, Richard; Nose, Yukihiko // American Journal of Gastroenterology;Oct1981, Vol. 76 Issue 4, p330 

    Patients with uncontrollable pruritus secondary to cholestatic liver disease were subjected to plasma perfusion in an attempt to remove the toxins responsible for this symptom. The improvement in the degree of pruritus was dramatic and surprisingly long-lasting in five of six patients. One...

  • Bile Acids and Collagenous Colitis. DeBaise, J. K.; Thompson, Jon S. // American Journal of Gastroenterology;Jul2000, Vol. 95 Issue 7, p1625 

    Discusses research being done on the role of bile acid binding agents in patients with collagenous colitis. Reference to a study by A. Kilander and colleagues published in a 2000 issue of "Gut" journal; Characteristics of collagenous colitis; Outcome of the bile acid binding treatment...

  • ¿MEJORA EL USO DE ÁCIDO URSODEOXICÓLICO EL PRONÓSTICO PERINATAL EN MUJERES EMBARAZADAS CON COLESTASIA INTRAHEPÁTICA DEL EMBARAZO? Morgan S., Gonzalo; Villalón S., Valentina; Danilla E., Stefan; ViIlavicencio F., Luis; Kottmann G., Cristián; Illanes L., Sebastian // Revista Chilena de Obstetricia y Ginecología;2007, Vol. 72 Issue 5, p292 

    Intrahepatic cholestasis of pregnancy (ICP) is a disease of the third trimester of pregnancy involving pruritus and elevated bile acid levels. Once thought to be benign for both mother and fetus, lCP has been associated with maternal jaundice and increased rates of fetal morbidity and mortality....

  • Rifampicin and treatment of cholestatic pruritus. Hofmann, A.F. // Gut;Nov2002, Vol. 51 Issue 5, p756 

    Comments on a paper published in a previous issue of the periodical 'Gut,' which examined the effectiveness of rifampicin in the treatment of cholestatis pruritus.

  • Rifampicin.  // Reactions Weekly;6/16/2012, Issue 1406, p32 

    The article describes two case reports of patients with primary sclerosing cholangitis who experienced severe coagulopathy following treatment with rifampicin for refractory pruritus.

  • Targeting Farnesoid-X-Receptor: From Medicinal Chemistry to Disease Treatment. Fiorucci, S.; Mencarelli, A.; Distrutti, E.; Palladino, G.; Cipriani, S. // Current Medicinal Chemistry;Jan2010, Vol. 17 Issue 2, Special section p139 

    The farnesoid X receptor (FXRa) is a metabolic nuclear receptor and bile acid sensor expressed in the liver and intestine. Physiological studies have shown that FXR.. exerts regulatory roles in bile acids, lipid and glucose homeostasis. FXR ligands of steroidal and non-steroidal structure have...

  • Eupatilin attenuates bile acid-induced hepatocyte apoptosis. Park, Su Cheol; Yoon, Jung-Hwan; Kim, Won; Gwak, Geum-Youn; Kim, Kang Mo; Lee, Sung-Hee; Lee, Soo-Mi; Lee, Hyo-Suk // Journal of Gastroenterology;Aug2006, Vol. 41 Issue 8, p772 

    In cases of cholestasis, bile acids induce hepatocyte apoptosis by activating death receptor-mediated apoptotic signaling cascades. Eupatilin (5,7-dihydroxy-3,4,6-trimethoxyflavone) is a pharmacologically active ingredient found in Artemisia asiatica and exhibits cytoprotective effects against...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics